Management of Node-Positive and Oligometastatic Prostate Cancer

被引:8
|
作者
Broughman, James R. [1 ,2 ]
Chen, Ronald C. [1 ,2 ,3 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Radiat Oncol, CB 7512, Chapel Hill, NC 27599 USA
[2] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
关键词
STEREOTACTIC BODY RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; DELAYED ENDOCRINE TREATMENT; TERM-FOLLOW-UP; RADICAL PROSTATECTOMY; ANDROGEN-DEPRIVATION; RADIATION-THERAPY; LOCAL TREATMENT; HEPATIC RESECTION; PRIMARY TUMOR;
D O I
10.1016/j.semradonc.2016.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Historically, stage IV prostate cancer was considered incurable. Although node-positive and oligometastatic prostate cancers are both classified as stage IV, these likely represent distinct clinical groups, and some patients may be curable with aggressive multimodality treatments. There is a lack of randomized evidence, but retrospective studies suggest that radical prostatectomy or radiotherapy may improve survival in these patients. This is an area of great current research interest and prospective randomized trials are needed to help define the optimal treatments for these patients. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [41] Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy
    Shiota, Masaki
    Blas, Leandro
    Eto, Masatoshi
    CANCERS, 2022, 14 (11)
  • [42] Management of oligometastatic prostate cancer
    Miszczyk, Marcin
    Slusarczyk, Aleksander
    Quhal, Fahad
    Klemm, Jakob
    Matsukawa, Akihiro
    Przydacz, Mikolaj
    Bryniarski, Piotr
    Shariat, Shahrokh F.
    Rajwa, Pawel
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (01) : 35 - 39
  • [43] Oligometastatic prostate cancer management
    Kleinclauss, F.
    Thiery-Vuillemin, A.
    PROGRES EN UROLOGIE, 2019, 29 : S20 - S34
  • [44] Management of oligometastatic prostate cancer
    Marcin Miszczyk
    Aleksander Slusarczyk
    Fahad Quhal
    Jakob Klemm
    Akihiro Matsukawa
    Mikołaj Przydacz
    Piotr Bryniarski
    Shahrokh F. Shariat
    Paweł Rajwa
    memo - Magazine of European Medical Oncology, 2024, 17 : 35 - 39
  • [45] Phase I/II Study of Extreme Hypofractionated Stereotactic Body Radiation Therapy Boost to Prostate for Locally Advanced, Node-Positive and Oligometastatic Cancer
    Narang, Kushal
    Kadian, Mohit
    Venkatesan, K.
    Mishra, Saumyaranjan
    Bisht, Shyam
    Gupta, Deepak
    Banerjee, Susovan
    Kataria, Tejinder
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [46] Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (03): : 972 - 973
  • [47] INFLUENCE OF RADIOTHERAPY ON NODE-POSITIVE PROSTATE-CANCER TREATED WITH ANDROGEN ABLATION
    SANDS, ME
    POLLACK, A
    ZAGARS, GK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (01): : 13 - 19
  • [48] PROGNOSIS OF NODE-POSITIVE COLON CANCER
    COHEN, AM
    TREMITERRA, S
    CANDELA, F
    THALER, HT
    SIGURDSON, ER
    CANCER, 1991, 67 (07) : 1859 - 1861
  • [49] Pathologically Node-Positive Prostate Cancer Casting for Cure When the Die Is Cast?
    Ginsburg, Kevin B.
    Cher, Michael L.
    Kutikov, Alexander
    Morgan, Todd M.
    CANCER JOURNAL, 2020, 26 (01): : 58 - 63
  • [50] Survival Benefit of Radical Prostatectomy in Lymph Node-Positive Patients with Prostate Cancer
    Engel, Jutta
    Bastian, Patrick J.
    Baur, Helmut
    Beer, Volker
    Chaussy, Christian
    Gschwend, Juergen E.
    Oberneder, Ralph
    Rothenberger, Karl H.
    Stief, Christian G.
    Hoelzel, Dieter
    EUROPEAN UROLOGY, 2010, 57 (05) : 754 - 761